LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours
Authors
Keywords
-
Journal
GUT
Volume 65, Issue 10, Pages 1765-1775
Publisher
BMJ
Online
2015-07-24
DOI
10.1136/gutjnl-2014-308810
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic Profiling of Hepatocellular Adenomas Reveals Recurrent FRK-Activating Mutations and the Mechanisms of Malignant Transformation
- (2014) Camilla Pilati et al. CANCER CELL
- Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
- (2014) Monika Julia Wolf et al. CANCER CELL
- The Lymphotoxin Network: Orchestrating a Type I interferon response to optimize adaptive immunity
- (2014) Jennifer L. Gommerman et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells
- (2014) Hélène Dubois-Pot-Schneider et al. HEPATOLOGY
- Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues
- (2014) Theresa T. Lu et al. Frontiers in Immunology
- The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations
- (2014) Xavier Bisteau et al. Cancers
- A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas
- (2013) Steffen Zender et al. CANCER CELL
- Modeling Pathogenesis of Primary Liver Cancer in Lineage-Specific Mouse Cell Types
- (2013) Ágnes Holczbauer et al. GASTROENTEROLOGY
- Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
- (2013) Daniela Sia et al. GASTROENTEROLOGY
- LIGHT/TNFSR14 Can Regulate Hepatic Lipase Expression by Hepatocytes Independent of T Cells and Kupffer Cells
- (2013) Bijoy Chellan et al. PLoS One
- Lymphotoxin Signaling Is Initiated by the Viral Polymerase in HCV-linked Tumorigenesis
- (2013) Yannick Simonin et al. PLoS Pathogens
- c-Myc and Cancer Metabolism
- (2012) D. M. Miller et al. CLINICAL CANCER RESEARCH
- Cholangiocarcinomas can originate from hepatocytes in mice
- (2012) Biao Fan et al. JOURNAL OF CLINICAL INVESTIGATION
- Next-generationsequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors
- (2012) Giuliana Amaddeo et al. OncoImmunology
- Coactivation of AKT and -Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
- (2011) J. K. Stauffer et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Maintaining embryonic stem cell pluripotency with Wnt signaling
- (2011) S. Y. Sokol DEVELOPMENT
- Risk factors for cholangiocarcinoma
- (2011) Gia L. Tyson et al. HEPATOLOGY
- Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice
- (2011) Eleni Maniati et al. JOURNAL OF CLINICAL INVESTIGATION
- IKKα Activation of NOTCH Links Tumorigenesis via FOXA2 Suppression
- (2011) Mo Liu et al. MOLECULAR CELL
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Cancer gene discovery in hepatocellular carcinoma
- (2010) Lars Zender et al. JOURNAL OF HEPATOLOGY
- A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
- (2009) Johannes Haybaeck et al. CANCER CELL
- Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt
- (2009) Dong Bai et al. INTERNATIONAL JOURNAL OF CANCER
- Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions
- (2009) Anna Kakehashi et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease
- (2008) Jeffrey L. Browning IMMUNOLOGICAL REVIEWS
- Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways
- (2008) Carl F. Ware IMMUNOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now